Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eaton Vance Ohio Municipal Income Trust (NQ:EVO)

4.260 +0.020 (+0.47%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eaton Vance Ohio Municipal Income Trust

< Previous 1 2 3 4 5 6 7 8 9 Next >
Just - Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program
Via ACCESSWIRE
German Drug Developer Evotec Seeks Adviser Input As Takeover Concerns Mount
Evotec consults defense advisers following a significant share price decline, raising concerns about a potential takeover. 
Via Benzinga
Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Evotec Reports Q1 2024 Results and Provides Corporate Update
Via ACCESSWIRE
Why Nurix Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Via Benzinga
AMC Networks, Louisiana-Pacific And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Evotec Announces Progress in Neuroscience Collaboration with Bristol Myers Squibb
Via ACCESSWIRE
Evotec SE: Results of the Annual General Meeting 2024
Via ACCESSWIRE
Evotec, Inserm, Lille University Hospital and Inserm Transfert Enter Collaboration to Identify Novel Therapeutic Targets in Obesity and Metabolic Diseases
Via ACCESSWIRE
Evotec and CHDI Foundation Extend Strategic Drug Discovery Collaboration in Huntington’s Disease
Via ACCESSWIRE
EVO Stock Earnings: Evotec Beats EPS, Beats Revenue for Q1 2024
EVO stock results show that Evotec beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Evotec SE to Announce Results for First Quarter 2024 on 22 May 2024
Via ACCESSWIRE
CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease
From Centogene NV
Via GlobeNewswire
3 Growth Stocks to Buy at 52-Week Lows
Looking for some compelling bargains? It's time to add these three growth stocks at 52-week lows to your watchlist. 
Via InvestorPlace
Bayer and Evotec Collaborate to Advance Precision Cardiology
Via ACCESSWIRE
Crude Oil Moves Lower; B. Riley Financial Shares Jump
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Dow Dips Over 100 Points; Ribbon Communications Shares Spike Higher
Via Benzinga
Topics Stocks
Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Nasdaq Rises 0.5%; Tesla Shares Jump After Q1 Results
Via Benzinga
Life Science-Focused Evotec Shares Plunge To 6 Year Lows On Gloomy Annual Forecast
Evotec undergoes a strategic shift for sustainable growth in 2024. Priority reset to optimize operations; expect double-digit revenue growth & EBITDA improvement. New CEO appointed. Guidance and... 
Via Benzinga
Why Is Fabrinet (FN) Stock Down Today?
Fabrinet stock is falling on Wednesday after the company provided FN investors with a date for its upcoming earnings report. 
Via InvestorPlace
Why Is Evotec (EVO) Stock Down 33% Today?
Evotec stock is falling on Wednesday as EVO investors react to a lackluster 2024 revenue guidance in its 2023 earnings results. 
Via InvestorPlace
Why Tesla Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
We are starting off Wednesday with a breakdown of the biggest pre-market stock movers traders will want to read about this morning! 
Via InvestorPlace
Enphase Energy Reports Weak Results, Joins Lithia Motors And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
Evotec Presents Fiscal Year 2023 Results and Announces Priority Reset to Focus on Profitable Growth
Via ACCESSWIRE
Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer
Via ACCESSWIRE
Evotec and Variant Bio Enter Strategic Partnership to Discover and Develop Fibrosis Treatments
Via ACCESSWIRE
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.